Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-09

Clinical Trial Update: Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction [NA]

View source ↗

Summary

Clinical trial evaluating pulmonary artery denervation for heart failure with preserved ejection fraction (HFpEF); the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Heart Failure With Preserved Ejection Fraction | NA | Status: NOT_YET_RECRUITING